The Burrill Report
The Burrill Report
Stop FollowingThe Burrill Report
View as an RSS Feed
View The Burrill Report's Articles BY TICKER:
ABT,
AFFX,
AFFY,
AMGN,
AMRS,
AZN,
BIIB,
BSX,
CELG,
CEPH,
CI,
CLVS,
CRL,
CRXL,
CTIC,
CYPB,
DCGN,
DD,
DNDN,
ELN,
ENDP,
EXEL,
FRX,
GE,
GERN,
GILD,
GLPYY.PK,
GNMSF.PK,
GNOM,
GSK,
HPTX,
HZNP,
ILMN,
IYH,
JNJ,
LIFE,
LLY,
MACK,
MDVN,
MNKD,
MRK,
MYGN,
NVS,
OREX,
PFE,
RHHBY.OB,
RIGL,
RPTP,
SHPG,
SI,
SNY,
SZYM,
TEVA,
VRTX,
VVUS,
WLP,
WX,
WYE,
XOMA,
XPH
- Dendreon Cuts Jobs As It Battles Weak Sales
- Hyperion Therapeutics Goes Public
- Dr. Reddy's And Merck Serono Partner On Biosimilars
- Vertex's Cystic Fibrosis Drug Impresses Investors
- Illumina Stays Independent But Drops As Roche's Offer Expires
- Endocyte Scores With Merck Partnership
- Roche Hints At Negotiating Room In Illumina Bid
- Amgen And AstraZeneca To Collaborate On Inflammation Portfolio
- Merrimack IPO Falls Out Of The Gate
- Affymax's Anemia Drug Will Create Added Competition For Amgen
- Roche And Illumina Duke It Out Ahead Of Annual Meeting
- Acquisition Could Jump-Start Boston Scientific's Sluggish Cardiac Defibrillator Business
- Dendreon Faces New Competition As J&J Impresses With Prostate Cancer Drug
- Biogen And Samsung Advance Biosimilars Venture
- Galapagos Scores With Abbott Deal
- Vivus Soars On FDA Panel Recommendation For New Obesity Drug
- Hepatitis C Remains A Hot Play
- Amyris Finds Scaling Up More Difficult Than Expected
- Siemens Seeks Growth In Companion Diagnostics
- AstraZeneca Axes 7,300 Jobs, 12% Of Workforce
- 2 Life Sciences IPOs Debut Below Target
- Big Biotech Fuels M&A Activity
- 5 Pharma Setbacks This Week
- Teva Names A New CEO
- Pharmacyclics Scores Big With Janssen Biotech Deal
- Senators Question Pfizer's Lipitor Deals
- Affymetrix Will Pay $330 Million To Acquire eBioscience
- AstraZeneca Adds $100 Million To MedImmune Ventures
- Regeneron Challenges Genentech's Lucentis
- Merck Pays $950M To Settle Vioxx Criminal And Civil Settlement
- Pfizer Cuts Lipitor Deals To Fight Generics
- Geron Dumps Stem Cells For Cancer Focus